AzTrials
AzTrials

Disability PhysicalNCT06542601

Combined Motor and Cognitive Training for Older Adults With Motoric Cognitive Risk Syndrome (CMC-training)

An observational study of Disability Physical and Disabilities Mental, run by Xuanwu Hospital, Beijing at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To investigate the effects of a combined motor-cognitive intervention on the improvement of motor as well as cognitive function in community residents. Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
What is being tested?
Motor cognitive intervention
How many people
204 participants
Where
1 siteChina
Study dates
4 Jul 2024to 30 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Elderly people with Motoric Cognitive Risk living in Beijing community

Who may be able to join

  • Age 60-80 years; ≥ 9 years of education; Cognitive impairment: MMSE score 22-26; Slow gait:total walking time >4 seconds and ≤8 seconds in a 4-meter walk test; Agreed to participate in the study and signed an informed consent form.

Who cannot join

  • Dementia/suspected dementia; Suffering from diseases that affect cognitive function, such as cerebrovascular disease, Parkinson's syndrome, etc.; Taking medications related to cognitive improvement and psychiatric disorders, etc.; Recent heart attack, severe cerebrovascular disease, psychiatric disorders, etc.; other inability to persist in completing exercise cognitive interventions, such as suffering from severe musculoskeletal disorders; Participating in another clinical trial at the same time; Participation in an exercise and/or cognitive intervention in the past 6 months; Inability to complete content in studies such as neuropsychological scale assessments.

Trial locations and contacts

1 site in 1 country.

Yi Tang, MD., PhD. contact

00861083199456

tangyi@xwhosp.org

China1 site, 1 recruiting
  • Xuanwu Hospital, Capital Medical University

    Beijing, 100053

    Yi Tang, M.D., Ph.D., 00861083199456

    Recruiting

Other trials in China

About this study

Official title: Effect of Combined Motor and Cognitive Training on Older Adults With Motoric Cognitive Risk Syndrome in Community: a Randomized Controlled Study

To investigate the effects of a combined motor-cognitive intervention on the improvement of motor as well as cognitive function in community residents.

Read the detailed description

Cognitive training uses systematically designed tasks that are difficulty-adaptive for cognitive domains such as attention, memory, and logical reasoning to improve individual cognitive functioning. Internet-based Adaptive Multi-Cognitive Domain Cognitive Training is conducted 3 times per week for 30 minutes each time, and includes tasks such as delayed memory, paired memory, and inverse numerical breadth.

The exercise intervention was based on the M-Mobile multicomponent exercise program, in which older adults were instructed to complete exercise training at home at least three days per week. In all intervention groups, balance, sitting test and walking speed were assessed according to the Simple Physical Performance Battery (SPPB), and according to their scores, they were given exercise training, including flexibility, balance, aerobic training and resistance training.

Being tested
Motor cognitive intervention
Keywords
Motoric Cognitive Risk, Cognitive training, Exercise training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Motor cognitive interventionDevice

    Older adults were given cognitive training and motor training for 12 weeks using a tablet computer

Study groups in NCT06542601
Study groupRoleWhat they receive
TotalAll subjects
Receives: Device: Motor cognitive intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive function changes in the intervention group and the control group

    Changes in Montreal Cognitive Assessment Scale (MoCA) scores before and after intervention between the two groups

    Measured: 12 weeks

  2. Motor function changes in the intervention group and the control group

    Changes in Montreal Short Physical performance Battery (SPPB) scores before and after intervention between the two groups

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Aug 2024
  2. Study start4 Jul 2024
  3. Primary completion30 Jan 2025 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06542601
Sponsor's protocol ID
2022-234
Status last verified
Apr 2024
First submitted
4 Aug 2024
Last updated
7 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Disability Physical and Disabilities Mental, run by Xuanwu Hospital, Beijing at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yi Tang, MD., PhD. (00861083199456, tangyi@xwhosp.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive function changes in the intervention group and the control group (time frame: 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in